I agree! ALNY's chart will look like REGN's, just prettier. However, let's take $1B in market cap at a time. Each billion is worth approx. $15.88 PPS. The $4B mark will be at $63.52 but any earlier than expected data may us gap right over that mark. With share price technically breaking out and poised to move to $59-65 by SEP OPEX, any data would gap us up to the low 70s should it happen mid-September. ALNY's RNAi technology is best in breed and they have an incredibly promising future. My only concern is that big pharma will offer up 85-95 to buy ALNY while it is cheap. It has extremely high institutional ownership which bodes well moving forward. Time will tell but any shareholders or call buyers stand to make a tremendous return with very little downside risk. It has been a port in the storm as of late and is already showing it will be steaming out of port to clear sailing and open seas. Good luck longs!